Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature

被引：9

作者：

Newberry C. ^{[1
]}

Lynch K. ^{[1
]}

机构：

[1] Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Boulevard, 7th Floor, South Tower, Philadelphia, 19104, PA

来源：

Current Gastroenterology Reports | 2017年 / 19卷 / 8期

关键词：

Barrett’s esophagus; Dietary therapy; Eosinophilic esophagitis; Esophageal adenocarcinoma; Esophageal diseases; GERD;

D O I：

10.1007/s11894-017-0578-5

中图分类号：

学科分类号：

摘要：

Purpose of Review: Esophageal diseases represent a wide variety of conditions affecting esophageal anatomy, physiology, and motility. Therapy focuses on pharmacotherapy and endoscopic or surgical management. Dietary therapy can be considered in management algorithms for specific esophageal diseases. This review focuses on outlining the literature related to dietary therapy in gastroesophageal reflux disease, eosinophilic esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Recent Findings: Currently, data are strongest for dietary manipulation in eosinophilic esophagitis, specifically the six-food elimination diet. Dietary effects on gastroesophageal reflux disease are less clear, though newer research indicates that increased fiber with reduction in simple sugar intake may improve symptoms. In terms of Barrett’s esophagus and esophageal adenocarcinoma, antioxidant intake may affect carcinogenesis, though to an unknown degree. Summary: Outcomes data regarding dietary manipulation for the management of esophageal diseases is heterogeneous. Given the rising interest in non-pharmacological treatment options for these patients, continued research is warranted. © 2017, Springer Science+Business Media, LLC.

引用

共 70 条

[31]

The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Therapeutics., (2007)

[32]

Barrett’s oesophagus: diagnosis and management. Bmj., (2016)

[33]

Westhoff B., Brotze S., Weston A., Mcelhinney C., Cherian R., Mayo M.S., Et al., The frequency of Barrett’s esophagus in high-risk patients with chronic GERD, Gastrointestinal Endoscopy, 61, 2, pp. 226-231, (2005)

[34]

Shaheen N.J., Falk G.W., Iyer P.G., Gerson L.B., ACG clinical guideline: diagnosis and management of Barrett’s esophagus, Am J Gastroenterol, 111, 1, pp. 30-50, (2016)

[35]

Bhardwaj V., Horvat A., Korolkova O., Washington M.K., El-Rifai W., Dikalov S.I., Et al., Prevention of DNA damage in Barrett’s esophageal cells exposed to acidic bile salts, Carcinogenesis, 37, 12, pp. 1161-1169, (2016)

[36]

Ceglie A.D., Fisher D., Filiberti R., Blanchi S., Conio M., Barrett’s esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet, Clin Res Hepatol Gastroenterol, 35, 1, pp. 7-16, (2011)

[37]

Kubo A., Corley D.A., Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma, Am J Gastroenterol, 102, 10, pp. 2323-2330, (2007)

[38]

Diet and esophageal disease. Ann N Y Acad Sci, (2014)

[39]

Veugelers P.J., Porter G.A., Guernsey D.L., Casson A.G., Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma, Dis Esophagus, 19, 5, pp. 321-328, (2006)

[40]

Ibiebele T.I., Hughes M.C., Nagle C.M., Bain C.J., Whiteman D.C., Webb P.M., Dietary antioxidants and risk of Barrett’s esophagus and adenocarcinoma of the esophagus in an Australian population, Int J Cancer, 133, 1, pp. 214-224, (2013)

← 1 2 3 4 5 6 7 →